Clinical efficacy of alternative antiandrogen therapy in Japanese men with relapsed prostate cancer after first-line hormonal therapy

OKIHARA Koji; UKIMURA Osamu; KANEMITSU Noriyuki; MIZUTANI Yoichi; KAWAUCHI Akihiro; MIKI Tsuneharu

Art

J-GLOBAL ID：200902299498280320 Reference number：07A0223315

Clinical efficacy of alternative antiandrogen therapy in Japanese men with relapsed prostate cancer after first-line hormonal therapy

第1選択ホルモン療法後の前立腺癌再発日本人男性における代替抗アンドロゲン療法の臨床効果

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=07A0223315&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0223315&from=J-GLOBAL&jstjournalNo=W1347A") }}

Author (6)： , , , , ,
Material：
Volume： 14 Issue： 2 Page： 128-132 Publication year： Feb. 2007
JST Material Number： W1347A ISSN： 0919-8172 Document type： Article
Article type：原著論文 Country of issue： Australia (AUS) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0223315&from=J-GLOBAL&jstjournalNo=W1347A") }}

Sex hormones , Clinical application of antitumor(=antineoplastic)drugs , Drug therapy(=pharmacotherapy)for urogenital diseases

, ,

Reference (13)：

CRAWFORD, ED. Epidemiology of prostate cancer. Urology. 2003, 62, Suppl. 6A, 3-12
The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan 1999 : estimates based on data from 11 population-based cancer registries. Jpn. J. Clin. Oncol. 2004, 34, 352-356
Cancer Registration Committee of the Japanese Urological Association. Clinicopathological statistics on registered prostate cancer patients in Japan : 2000 report from the Japanese Urological Association. Int. J. Urol. 2005, 12, 46-61
SHER, HI. Bicalutamide for advanced prostate cancer : the natural versus treated history of disease. J. Clin. Oncol. 1997, 15, 2928-2938
KOJIMA, S. Alternative antiandrogens to treat prostate cancer relapse after initial hormone therapy. J. Urol. 2004, 171, 2 Pt 1, 679-683

ｍore...

, , , , , ,

Return to Previous Page